Hologic, Inc. (BMV:HOLX)

Market Cap	282.39B
Revenue (ttm)	76.13B
Net Income (ttm)	10.50B
Shares Out	n/a
EPS (ttm)	45.51
PE Ratio	26.89
Forward PE	15.18
Dividend	n/a
Ex-Dividend Date	n/a

Volume	11
Average Volume	n/a
Open	n/a
Previous Close	n/a
Day's Range	n/a
52-Week Range	1,263.00 - 1,263.00
Beta	n/a
RSI	n/a
Earnings Date	Nov 6, 2025

About Berry Global Group

Hologic, Inc. engages in the development, manufacture, and supply of diagnostics products, medical imaging systems, and surgical products for women's health through early detection and treatment worldwide. The company operates through four segments: Diagnostics, Breast Health, GYN Surgical, and Skeletal Health. It provides Aptima molecular diagnostic assays to detect the infectious microorganisms; Aptima viral load assays for Hepatitis B virus, Hepatitis C virus, human immunodeficiency virus, and human cytomegalo virus; Aptima bacterial vaginos...

• Industry: X-Ray Apparatus and Tubes and Related Irradiation Apparatus
• Founded: 1985
• Employees: 7,063
• Stock Exchange: Mexican Stock Exchange
• Ticker Symbol: HOLX

Financial Performance

In 2024, Hologic's revenue was $4.03 billion, a decrease of -0.00% compared to the previous year's $4.03 billion. Earnings were $789.50 million, an increase of 73.14%.